| Name | Rulonilimab |
|---|
| Description | Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |